Dansey Roger D

Dansey Roger D is listed in filings as Director at Inovio Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including 13 public disclosures. Recent filings connect the profile to Inovio Pharmaceuticals, Inc. (INO), Nurix Therapeutics, Inc. (NRIX), Bicycle Therapeutics plc (BCYC), and Kronos Bio, Inc. (KRON). The current snapshot covers public activity from Jun 26, 2024 to May 21, 2026. Reported amounts are shown as $51.4K to $42.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.